1,3-Benzodioxolyl-N-ethylbutanamine

EBDB
Names
	Preferred IUPAC name 1-(2H-1,3-Benzodioxol-5-yl)-N-ethylbutan-2-amine
	Other names 3,4-Methenedioxy-α,N-diethyl-phenethylamine; 3,4-Methylenedioxy-N-ethylbutanphenamine; MDEB
Identifiers
CAS Number	167394-39-0 ;
3D model (JSmol)	Interactive image;
ChemSpider	8389996;
PubChem CID	10214504;
UNII	5Y22MYG54G ;
CompTox Dashboard (EPA)	DTXSID90436778 ;
	InChI InChI=1S/C13H19NO2/c1-3-11(14-4-2)7-10-5-6-12-13(8-10)16-9-15-12/h5-6,8,11,14H,3-4,7,9H2,1-2H3 Key: IYZPKSQJPVUWRO-UHFFFAOYSA-N; InChI=1/C13H19NO2/c1-3-11(14-4-2)7-10-5-6-12-13(8-10)16-9-15-12/h5-6,8,11,14H,3-4,7,9H2,1-2H3 Key: IYZPKSQJPVUWRO-UHFFFAOYAT;
	SMILES O1c2ccc(cc2OC1)CC(NCC)CC;
Properties
Chemical formula	C13H19NO2
Molar mass	221.300 g·mol−1
Melting point	176 to 177 °C (349 to 351 °F; 449 to 450 K)
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Ethylbenzodioxolylbutanamine (EBDB; Ethyl-J) is a lesser-known entactogen, stimulant, and psychedelic of the phenethylamine, amphetamine, and phenylisobutylamine families. It is the N-ethyl analogue of benzodioxylbutanamine (BDB; "J"), and also the α-ethyl analogue of methylenedioxyethylamphetamine (MDEA; "Eve").

EBDB was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage consumed was 90 mg, and the duration is unknown.^[1] EBDB produced few to no effects at the dosage range tested in PiHKAL, but at higher doses of several hundred milligrams it produces euphoric effects similar to those of methylbenzodioxylbutanamine (MBDB; "Eden", "Methyl-J"), although milder and shorter lasting.^{[citation needed]}

Very little data exists about the pharmacological properties, metabolism, and toxicity of EBDB.

References

^ Ethyl-J Entry in PiHKAL

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[1] Ethyl-J Entry in PiHKAL

[1]

See also

References